AzTrials
AzTrials

Carotid StenosisNCT02336958

Ultrasound Guided Intermediate Cervical Plexus Block and Additional Perivascular Local Anesthetic Infiltration

A study testing intermediate cervical plexus block ropivacaine, pericarotidal infiltration (active comparator) ropivacaine and jugular infiltration prilocaine in people with Carotid Stenosis, run by Helios Research Center.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

For ultrasound guided intermediate cervical plexus block this randomized comparison is testing the hypothesis, that an additional perivascular infiltration is associated with increased block quality. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Carotid Stenosis
What is being tested?
intermediate cervical plexus block ropivacaine, pericarotidal infiltration (active comparator) ropivacaine and jugular infiltration prilocaine
Could I receive a placebo?
Yes, some participants may receive a placebo
How many people
40 participants
Where
No sites listed yet
Study dates
Sep 2013to Dec 2014
Phase
Interventional
Are there results?
Yes, posted in the registrySummary in the doctors' view

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • carotid surgery (symptomatic and asymptomatic carotid stenosis)
  • adult patients (18 years or older)
  • ASA-risk-groups I-IV
  • informed consent

Who cannot join

  • drug allergy: local anesthetics
  • pregnancy, lactation period
  • participation in other studies
  • addiction to drugs or alcohol
  • non-cooperative patients
  • no approval to regional anesthesia

About this study

Official title: Ultrasound Guided Intermediate Cervical Plexus Block -Randomized Evaluation Concerning the Significance of Additional Perivascular Local Anesthetic Infiltration

For ultrasound guided intermediate cervical plexus block this randomized comparison is testing the hypothesis, that an additional perivascular infiltration is associated with increased block quality.

Read the detailed description

The innervation of the neck is complex and involves the cervical and the brachial plexus as well as cranial nerves. So is the wall of the carotid arteries innervated by vagal and glossopharyngeal nerve as well as the sympathetic trunk. When carotid surgery was performed under regional anesthesia, so additional infiltration of local anesthetic by the surgeon was common, particularly during preparation of the carotid arteries.

Introduction of ultrasound guidance made it possible to guide the needle directly to the vascular wall. But this procedure is considered very demanding, because of guiding the needle in an anatomical region with artifacts (because of calcification), sudden movements (e.g. because of swallowing) and compromised coagulation (antithrombotic medication). On the other side there are no clinical data proving the benefit of an additional perivascular infiltration with local anesthetic. Therefore, this investigation is testing the hypothesis, that an additional perivascular infiltration is associated with increased block quality.

Being tested
intermediate cervical plexus block ropivacaine, pericarotidal infiltration (active comparator) ropivacaine, jugular infiltration prilocaine, pericarotidal infiltration (placebo comparator) saline
Keywords
cervical plexus, regional anesthesia, ultrasound, carotid surgery
Medical subject headings
Carotid Stenosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • intermediate cervical plexus block ropivacaineDrug

    20ml ultrasound guided intermediate cervical plexus block.

  • pericarotidal infiltration (active comparator) ropivacaineDrug

    5ml ropivacaine 0.75% (active comparator): pericarotidal infiltration.

  • jugular infiltration prilocaineDrug

    5ml prilocaine 1% jugular infiltration for wound drainage.

  • pericarotidal infiltration (placebo comparator) salineDrug

    5ml saline 0.9% (placebo comparator): pericarotidal infiltration.

Study groups in NCT02336958
Study groupRoleWhat they receive
ropivacaineActive comparatorUltrasound guided intermediate cervical plexus block: 20ml ropivacaine 0.75%. Ultrasound guided perivascular/pericarotidal infiltration: 5ml ropivacaine 0.75%.
Receives: Drug: intermediate cervical plexus block ropivacaine; Drug: pericarotidal infiltration (active comparator) ropivacaine; Drug: jugular infiltration prilocaine
salinePlacebo comparatorUltrasound guided intermediate cervical plexus block: 20ml ropivacaine 0.75%. Ultrasound guided perivascular/pericarotidal infiltration: 5ml saline 0.9%.
Receives: Drug: intermediate cervical plexus block ropivacaine; Drug: jugular infiltration prilocaine; Drug: pericarotidal infiltration (placebo comparator) saline

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Number of Patients With Required Supplementation of Local Anesthetic by Surgeon

    Measured: during the intraoperative period

  2. Amount (ml) of Local Anesthetic Supplemented by Surgeon

    Measured: during the intraoperative period

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted13 Jan 2015 (estimated)
  2. Study startSep 2013
  3. Primary completionDec 2014
  4. Study completionDec 2014

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Masking
Double blind
Who is masked
Participant, Investigator
Enrolment
40 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02336958
Sponsor's protocol ID
A 2013-0075
Status last verified
Mar 2015
First submitted
2 Jan 2015
Last updated
23 Mar 2015
Data monitoring committee
No

Questions about this trial

What is this clinical trial studying?

A study testing intermediate cervical plexus block ropivacaine, pericarotidal infiltration (active comparator) ropivacaine and jugular infiltration prilocaine in people with Carotid Stenosis, run by Helios Research Center.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 4 inclusion and 6 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 23 Mar 2015. Status can change between updates, so confirm with the study contact before making plans.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. Some participants in this study may receive a placebo. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

Yes. Results are posted in the registry (first posted 23 Mar 2015). A summary is in the For doctors view, and the full results are on ClinicalTrials.gov.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Number of Patients With Required Supplementation of Local Anesthetic by Surgeon (time frame: during the intraoperative period). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 23 Mar 2015.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in